ETR Associates
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, ETR Associates sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
ETR Associates: 6 sponsored US clinical trials, 1 recruiting.
ETR Associates sponsors 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 5 completed. The most-studied condition in this pipeline is HIV/AIDS and Infections, with 1 trials.
Upper-quartile sponsor footprint
ETR Associates sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
NCT06581536
PrEPTECH Phase 2 Study of a PrEP Telehealth Intervention
NCT04902820
Evaluation of the Trans Women Connected Mobile App for Changes in Sexual Health-related Behavior Among Transgender Women
NCT03897049
Evaluation of 3T, a Sex-Positive HIV/STI Mobile App Intervention for Young Black Men Ages 14-19 Attracted to Men
NCT04135443
A Healthy Relationships Program for Vulnerable Youth
NCT03736876
Rigorous Evaluation of High School FLASH
NCT04079608
What is open in the ETR Associates pipeline
1 recruiting of 6 indexed (17% open); 5 completed (83%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: HIV/AIDS and Infections (1 trial), 8 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
ETR Associates: open-pipeline peers nationwide
Peers matched on 6 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
ETR Associates sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
- Akamis Bio · 17% recruiting · 6 trials
- Angiodynamics · 17% recruiting · 12 trials
Related
What to do with this ETR Associates page
6 registered trials is a research-attention snapshot, not an endorsement of ETR Associates or any single study.
- 1 of ETR Associates's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- HIV/AIDS and Infections is the condition ETR Associates studies most, compare against other sponsors active in the same condition before evaluating a specific study. See HIV/AIDS and Infections trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
ETR Associates pipeline card: 6 registered trials from official public datasets.Report a data error.